HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 135,003 shares of the company's stock after selling 7,474 shares during the period. Victory Capital Management Inc. owned approximately 0.05% of HCA Healthcare worth $54,869,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Capital World Investors raised its holdings in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company's stock valued at $931,342,000 after buying an additional 1,019,750 shares during the last quarter. Lee Danner & Bass Inc. bought a new position in HCA Healthcare during the 2nd quarter valued at $131,527,000. Darsana Capital Partners LP raised its stake in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Swedbank AB bought a new stake in shares of HCA Healthcare during the 1st quarter worth $95,882,000. Finally, Argent Capital Management LLC increased its holdings in HCA Healthcare by 1,215.6% in the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company's stock worth $51,493,000 after acquiring an additional 148,092 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

HCA stock traded down $4.98 during midday trading on Friday, reaching $340.53. The stock had a trading volume of 1,029,251 shares, compared to its average volume of 1,182,578. The firm has a fifty day simple moving average of $386.00 and a two-hundred day simple moving average of $357.03. The stock has a market cap of $86.26 billion, a PE ratio of 15.15, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $238.82 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HCA. Wells Fargo & Company boosted their price objective on HCA Healthcare from $395.00 to $400.00 and gave the stock an "equal weight" rating in a report on Wednesday, November 6th. TD Cowen reduced their target price on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. KeyCorp reduced their price target on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Leerink Partners upped their price target on HCA Healthcare from $367.00 to $396.00 and gave the company an "outperform" rating in a report on Wednesday, July 24th. Finally, Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $385.00.

Insider Buying and Selling

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company's stock, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.60% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.